Home › NDC Lookup › RxCUI directory › RxCUI 904170

Primaquine phosphate 26.3 MG Oral Tablet — RxCUI 904170

RxNorm drug concept · Semantic clinical drug
RxCUI 904170 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI904170
Official namePrimaquine phosphate 26.3 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asprimaquine phosphate 26.3 MG (primaquine 15 MG) Oral Tablet
FDA products mapped5
Package NDCs mapped7
Reported Medicaid activity (SDUD)53 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Primaquine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Great question — this trips a lot of people up. Chloroquine clears the malaria parasites from your blood quickly and stops the active illness. But with vivax malaria, some parasite...
  • Why do I need to take primaquine if I already took chloroquine for malaria?
  • G6PD is an enzyme that helps protect your red blood cells from damage. Some people — particularly those with ancestry from Africa, the Mediterranean, the Middle East, South-East As...
  • What is G6PD deficiency, and why does my doctor need to test me before I start?
📖 Read our full Primaquine guide →

🕸️ Concept Web — How Primaquine phosphate 26.3 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Primaquine phosphate 26.3 MG Oral Tablet RxCUI 904170

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Primaquine 8687
    • Primaquine phosphate 8689
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Primaquine Oral Tablet 374409
    • Primaquine phosphate Oral Tablet 2646100
    • Primaquine Oral Product 1161715
    • Primaquine Pill 1161716
    • Primaquine phosphate Oral Product 2660074
    • Primaquine phosphate Pill 2661382
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Primaquine phosphate 26.3 MG 904169

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Primaquine phosphate 26.3 MG SCDC · 904169
  • Primaquine Oral Tablet SCDF · 374409
  • Primaquine phosphate Oral Tablet SCDFP · 2646100
  • Primaquine Oral Product SCDG · 1161715
  • Primaquine Pill SCDG · 1161716
  • Primaquine phosphate Oral Product SCDGP · 2660074
  • Primaquine phosphate Pill SCDGP · 2661382

📦 FDA Products & Package NDCs

5 products · 7 package NDCs
7 package NDCs map to RxCUI 904170 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00024-1596-01 100 TABLET, FILM COATED in 1 BOTTLE (0024-1596-01) Primaquine Phosphate Sanofi-Aventis U.S. LLC 2011-04-15
42291-0510-01 100 TABLET, FILM COATED in 1 BOTTLE (42291-510-01) PRIMAQUINE PHOSPHATE AvKARE 2019-02-21
43063-0721-14 14 TABLET in 1 BOTTLE, PLASTIC (43063-721-14) Primaquine Phosphate PD-Rx Pharmaceuticals, Inc. 2016-10-17
43063-0721-28 28 TABLET in 1 BOTTLE, PLASTIC (43063-721-28) Primaquine Phosphate PD-Rx Pharmaceuticals, Inc. 2016-10-17
50742-0191-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50742-191-01) PRIMAQUINE PHOSPHATE Ingenus Pharmaceuticals, LLC 2018-01-23
50742-0191-05 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50742-191-05) PRIMAQUINE PHOSPHATE Ingenus Pharmaceuticals, LLC 2018-01-23
76385-0102-01 100 TABLET in 1 BOTTLE (76385-102-01) Primaquine Phosphate Unichem Pharmaceuticals (USA), Inc. 2014-08-01
Observed labelers: Ingenus Pharmaceuticals, LLC (2) · PD-Rx Pharmaceuticals, Inc. (2) · AvKARE (1) · Sanofi-Aventis U.S. LLC (1) · Unichem Pharmaceuticals (USA), Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.